Clinical and Economic Burden of Pneumococcal Disease Due to Serotypes Contained in Current and Investigational Pneumococcal Conjugate Vaccines in Children Under Five Years of Age

INTRODUCTION: The widespread implementation of pneumococcal conjugate vaccines (PCVs) has significantly reduced the burden of pneumococcal disease around the world. Although licensed 10-valent (PCV10) and 13-valent (PCV13) vaccines have considerably reduced mortality and morbidity, a sizeable diseas...

Descripción completa

Detalles Bibliográficos
Autores principales: Wasserman, Matt D., Perdrizet, Johnna, Grant, Lindsay, Hayford, Kyla, Singh, Shubhra, Saharia, Paranjoy, Horn, Emily K., Farkouh, Raymond A.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Healthcare 2021
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8503717/
https://www.ncbi.nlm.nih.gov/pubmed/34633639
http://dx.doi.org/10.1007/s40121-021-00544-1

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8503717/
https://www.ncbi.nlm.nih.gov/pubmed/34633639
http://dx.doi.org/10.1007/s40121-021-00544-1

Ejemplares similares